Results 11 to 20 of about 11,791 (220)

Keratoscleritis and Choroidal Exudative Detachment in the Setting of Ocular Pyoderma Gangrenosum. [PDF]

open access: yesCase Rep Ophthalmol Med
Purpose The purpose of this study is to report a rare case of ocular pyoderma gangrenosum (PG) presenting as keratoscleritis with choroidal effusion following cataract surgery and to highlight its clinical recognition and management. Methods A 79‐year‐old man developed a corneal ulcer 2 days after uncomplicated phacoemulsification with intraocular lens
Bodeen J   +3 more
europepmc   +2 more sources

A clinical study of episcleritis and scleritis

open access: yesTNOA Journal of Ophthalmic Science and Research, 2021
Purpose: Episcleritis and scleritis, considered as different forms of the same spectrum of disease, are clinically distinct, having different prognosis and requiring different management.
Pawan N Jarwal
doaj   +1 more source

Identifying TNF and IL6 as potential hub genes and targeted drugs associated with scleritis: A bio-informative report

open access: yesFrontiers in Immunology, 2023
BackgroundScleritis is a serious inflammatory eye disease that can lead to blindness. The etiology and pathogenesis of scleritis remain unclear, and increasing evidence indicates that some specific genes and proteins are involved.
Feiyue Yan   +5 more
doaj   +1 more source

Tubercular scleritis

open access: yesKathmandu University Medical Journal, 2012
Scleritis is a severe painful inflammatory process centred in the sclera. A scleritis may be a harbinger of many systemic diseases so that it is important to exclude multisystem disease. We describe a case of unilateral tubercular anterior nodular non-necrotizing scleritis.
R, Sharma, S, Marasini, B P, Nepal
openaire   +3 more sources

Colombian ocular inflammatory diseases epidemiology study (COIDES): prevalence, incidence and sociodemographic characterisation of Scleritis in Colombia, 2015–2020

open access: yesBMJ Open Ophthalmology, 2022
Objective To describe the epidemiological and demographic characteristics of scleritis in Colombia.Methods and analysis Population-based study using the national database from the Colombian Ministry of Health, using the International Classification of ...
William Rojas-Carabali   +7 more
doaj   +1 more source

Vogt-Koyanagi-Harada Syndrome in Two Patients with Immunoglobulin A Nephropathy [PDF]

open access: yes, 2007
We describe herein 2 patients who developed Vogt-Koyanagi-Harada syndrome in the course of renal biopsy-proven immunoglobulin A (IgA) nephropathy. A 61-year-old man with an 11-year history of IgA nephropathy and a 16-year history of thyroiditis, and a 56-
Masuda, Ikuya   +5 more
core   +1 more source

Plasmapheresis as a viable treatment option for scleritis

open access: yesAmerican Journal of Ophthalmology Case Reports, 2022
Purpose: We describe a case and our experience with using plasmapheresis as a treatment for scleritis. Observations: Treating relapsing autoimmune scleritis can be challenging when it inadequately responds to traditional therapy.
Janine M. Preble, Xihui Lin
doaj   +1 more source

Tibial Periosteum For The Surgical Perforation [PDF]

open access: yes, 2016
Purpose: Report a successful case of scleral perforation repair, refractive to treatment with bank-scleral graft, using pretibial periosteum graft patch.
Mateo A   +5 more
core   +1 more source

Systemic Cyclosporine Therapy for Scleritis: A Proposal of a Novel System to Assess the Activity of Scleritis

open access: yesCase Reports in Ophthalmology, 2015
In the present study, two female patients with unilateral scleritis without systemic complications were examined. Both patients were suffering from ocular pain and received corticosteroid therapy.
Haruka Aoki   +3 more
doaj   +1 more source

Case report-immune recovery posterior scleritis in a HIV positive patient

open access: yesBMC Ophthalmology, 2020
Background Posterior scleritis is an uncommon vision-threatening disorder that is often recurrent and difficult to cure due to its complex etiology.
Xin Che   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy